Clinical Trials Browser

Phase NA × Carcinoma, Non-Small-Cell Lung × Gefitinib × Clear all

Carcinoma, Non-Small-Cell Lung

NCT02148380 2016-04-20

Combination of Chemotherapy and Gefitinib as First-line Treatment

Phase NA Completed

121 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00068497 2013-01-14

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Phase NA Completed

40 enrolled

CNSEndocrineHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Thyroid Cancer, Papillary, Carcinoma, Non-Small-Cell Lung, Parathyroid Neoplasms, Salivary Gland Neoplasms, Thyroid Neoplasms, Tongue Neoplasms, Adenocarcinoma, Follicular, Carcinoma, Medullary, Esthesioneuroblastoma, Olfactory, Thyroid Carcinoma, Anaplastic

NCT00104728 2012-10-31

Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates

Phase NA Terminated

42 enrolled 3 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Bone Metastasis on the Survival of Gefitinib Effective Patients

Combination of Chemotherapy and Gefitinib as First-line Treatment

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

Neoadjuvant IRESSA As Single Agent PreopTherapy for NSCLC With Molecular Correlates